Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2010
08/10/2010US7771728 Hyperimmune serum-reactive antigen for use in prevention and treatment of tumor, allergen or metabolic disorders
08/10/2010US7771727 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
08/10/2010US7771725 vaccine; for dengue, yellow fever, West Nile , chikungunya, Ross River, O'nyong-nyong, and Mayaro viruses
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010US7771721 Methods for using chimeric vascular endothelial growth factor receptor proteins
08/10/2010CA2383493C Treating prostate cancer with anti-erbb2 antibodies
08/10/2010CA2350398C Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
08/10/2010CA2267095C Nucleotide and protein sequence of mammastatin and methods of use
08/10/2010CA2253239C Antibodies against interferon alpha/beta receptor
08/10/2010CA2235627C Receptor and nucleic acid molecule encoding said receptor
08/10/2010CA2223491C Cdr-grafted anti-tissue factor antibodies and methods of use thereof
08/10/2010CA2165969C Vertebrate apoptosis gene: compositions and methods
08/10/2010CA2124583C Synthetic compounds and compositions with enhanced cell binding
08/05/2010WO2010088691A2 Compositions and methods for treating or preventing conditions and diseases associated with mannheimia haemolytica
08/05/2010WO2010088522A2 Novel lowered affinity antibodies and uses therefor
08/05/2010WO2010088444A1 Human anti-il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
08/05/2010WO2010087972A2 Il-1 binding proteins
08/05/2010WO2010087743A2 The use of a protein in stem cell and cancer applications
08/05/2010WO2010087434A1 Method for detecting pancreatic cancer
08/05/2010WO2010087131A1 Hiv replication inhibitor, and use thereof
08/05/2010WO2010086854A1 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
08/05/2010WO2010086828A2 Agonist anti-trkb monoclonal antibodies
08/05/2010WO2010086512A2 Novel peptides and methods for producing them
08/05/2010WO2010086445A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010WO2010086353A1 A clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
08/05/2010WO2010086163A1 Tumor markers and methods of use thereof
08/05/2010WO2010085879A1 Urine and serum biomarkers associated with diabetic nephropathy
08/05/2010WO2010085878A1 Biomarkers associated with nephropathy
08/05/2010WO2010067286A3 IgE CH3 PEPTIDE VACCINE
08/05/2010WO2010066836A3 Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
08/05/2010WO2010066689A3 Modulators of the interaction between cholesterol molecules and the epstein-barr virus induced receptor 2
08/05/2010WO2010060100A3 Antibodies directed against calcium channel subunit alpha2/delta and mehtods using same
08/05/2010WO2010045589A3 Optimizing erythropoietin therapy
08/05/2010WO2010014784A3 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
08/05/2010WO2009148575A8 IL-1α ABS AND METHODS OF USE
08/05/2010WO2009142773A3 Multivalent fibronectin based scaffold domain proteins
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
08/05/2010US20100199367 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
08/05/2010US20100199365 Desaturases and methods for producing polyunsaturated fatty acids in transgenic organisms
08/05/2010US20100199363 Enzymes for degrading herbicides
08/05/2010US20100197897 Binding molecules
08/05/2010US20100197896 Functional humanization of complementarity determining regions (cdrs)
08/05/2010US20100197895 Antibodies to human tumor necrosis factor receptor
08/05/2010US20100197894 Method and apparatus for material separation using acoustic energy
08/05/2010US20100197808 Method for identifying mhc alleles in dogs
08/05/2010US20100197771 Influenza virus vaccine composition and methods of use
08/05/2010US20100197768 Methods and compositions related to the structure and function of apobec3g
08/05/2010US20100197579 Corticotropin Releasing Factor 2 Receptor Agonists
08/05/2010US20100197576 Polypeptides or fusion proteins thereof inhibiting transmigration of leucocytes or growth and/or metastasis of cancer cells
08/05/2010US20100197561 Biomarkers for Ovarian Cancer: B2 Microglobulin
08/05/2010US20100197030 Xanthene dyes comprising a sulfonamide group
08/05/2010US20100197011 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
08/05/2010US20100197009 Antibody or Fragment Thereof Recognizing AvitagTM and Uses Thereof
08/05/2010US20100196989 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
08/05/2010US20100196961 Variable tangential flow filtration
08/05/2010US20100196931 Determination of responders to chemotherapy
08/05/2010US20100196919 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease
08/05/2010US20100196891 IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer
08/05/2010US20100196524 Novel peptides and methods for producing them
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196410 Streptococcus pneumoniae Antigens and Vaccines
08/05/2010US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
08/05/2010US20100196407 Tick galectin
08/05/2010US20100196403 Antibody conjugates for circumventing multi-drug resistance
08/05/2010US20100196400 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
08/05/2010US20100196398 Targeted binding agents directed to cd105 and uses thereof
08/05/2010US20100196395 Anti-igf antibodies
08/05/2010US20100196394 Anti-cancer vaccine composition
08/05/2010US20100196392 Anti-system asc amino acid transporter 2 (asct2) antibody
08/05/2010US20100196390 Agonist anti-trkb monoclonal antibodies
08/05/2010US20100196388 Targeted binding agents directed to sonic hedgehog homolog and uses thereof
08/05/2010US20100196386 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
08/05/2010US20100196385 Targeted binding agents directed to dll4 and uses thereof 524
08/05/2010US20100196384 Anti-histone h1 monoclonal antibody and hybridoma for the production thereof
08/05/2010US20100196383 Connective Tissue Growth Factor (CTGF-3)
08/05/2010US20100196382 Nontypeable Haemophilus Influenzae Virulence Factors
08/05/2010US20100196381 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
08/05/2010US20100196379 Group B Streptococcus Polypeptides Nucleic Acids and Therapeutic Compositions and Vaccines Thereof
08/05/2010US20100196376 Method for reducing allergen-induced airway hyperresponsiveness
08/05/2010US20100196375 Engineered scFv against Bovine Herpes Virus Type I
08/05/2010US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof
08/05/2010US20100196371 Method of modulating the activity of functional immune molecules
08/05/2010US20100196370 Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment
08/05/2010US20100196367 Methods For Screening Candidate Agents For Modulating Prorenin And Renin, Assays for Detecting Prorenin And Antibodies
08/05/2010US20100196364 Monoclonal antibodies to fibroblast growth factor receptor 2
08/05/2010US20100196362 Engineering Fc Antibody Regions to Confer Effector Function
08/05/2010US20100196361 Method of inhibition of vascular development using an antibody
08/05/2010US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant
08/05/2010US20100196359 Human Monoclonal Antibody Human CD134 (Ox40) and Methods of Making and Using Same
08/05/2010US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
08/05/2010US20100196271 Cage-Like Bifunctional Chelators, Copper-64 Radiopharmaceuticals and PET Imaging Using the Same
08/05/2010US20100196266 Humanized Anti-HLA-DR Antibodies
08/05/2010US20100196265 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
08/05/2010CA2750988A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010CA2750952A1 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
08/05/2010CA2750576A1 Novel peptides and methods for producing them
08/05/2010CA2749966A1 Il-1 binding proteins
08/05/2010CA2749200A1 Human anti-il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
1 ... 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 ... 1494